A Study to Assess Adverse Events and How Oral ABBV-932 Moves Through the Body When Given With Oral Itraconazole in Adult Participants With Bipolar Disorder

Clinical trial NCT07071532 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07071532
Sponsor: AbbVie
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Bipolar Disorder

Start date: 2026-08-21
Primary completion: 2027-02-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.